Paul Christiansen, Sally Hunt, Andrew Jones & Abigail K. Rose (10 Jul 2024): Development and Validation of the Maternal Drinking Motives Scale (M-DMS), Substance Use
Paul Christiansen, Sally Hunt, Andrew Jones & Abigail K. Rose (10 Jul 2024): Development and Validation of the Maternal Drinking Motives Scale (M-DMS), Substance Use
In this webinar recording, presenters provide advice and expertise to help communities prepare for FASD Awareness Month in September.
Introduction Marijuana is the most commonly used drug of abuse during pregnancy in the United States,1 with self-reported use ranging from 2–5% for all women and
Backer KD, Rayment-Jones H, Lever Taylor B, Bicknell-Morel T, Montgomery E, Sandall J, et al. (2024) Healthcare experiences of pregnant and postnatal women and healthcare
Lepow L, Wagner A, Peri S, Adams F, Ramakrishnan SA, Alam MA, Shaik RB, Hubbard NA, Koenigsberg HW, Hurd Y, Tapert SF, Ivanov I, Parvaz
ABSTRACTIntroduction: the teratogenic agents during the embryonic period can result in disorders in organ differentiation. Concerns regarding medication use during pregnancy heightened after the thalidomide